Skip to content

Role of Vitamic C and E in high blood pressure during pregnancy

Effect of antioxidant in women at risk of developing preeclamsia â?? A placebo controlled double blind randomized trial

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/03/032346
Enrollment
721
Registered
2021-03-26
Start date
Unknown
Completion date
Unknown
Last updated
2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O140- Mild to moderate pre-eclampsia

Interventions

Intervention1: Vit C (1000 MG) and Vit E (400 IU) and Placebo: 1000 mg of Vitc and 400 IU of Vit E Route of administration-oral Frequency of administration- once daily Control Intervention1: Placebo:

Sponsors

JIPMER pONDICHERRY
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Inclusion criteria: Pregnant women presenting in antenatal clinic of JIPMR between 14- 22 weeks of gestation with one or more risks factors a. preeclampsia/eclampsia in previous pregnancy, b. chronic hypertension, c. renal disease, d. HELLP syndrome in prior pregnancy, e. pregestational diabetes, f. women with BMI 30 kg/m2, g. antiphospholipid syndromes, h. multifetal pregnancy, i. thrombophilia, j. Assisted reproductive technique conception, k. age more than 35 years

Exclusion criteria

Exclusion criteria: B. Exclusion criteria: 1. Pregnant women less than 18 years 2. Women with known cardiac lesion 3. Women with known chronic respiratory disease (Tuberculosis, COPD, Bronchial asthma) 4.Women receiving warfarin therapy 5.Women unable to give informed consent

Design outcomes

Primary

MeasureTime frame
Primary outcome measure includes incidence of preeclampsia/eclampsia, early onset preeclampsia.Timepoint: in third trimester of pregnancy, and early postpartum period

Secondary

MeasureTime frame
Maternal and fetal complications Systolic and Diastolic functionTimepoint: pregnancy and postpartum period

Countries

India

Contacts

Public ContactDr Nivedita

JIPMER, Puducherry

dr.niveditajha@gmail.com09487581663

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026